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ABSTRACT 
This project examines longitudinal associations between serum C-reactive protein 
(CRP) levels, measured using a high-sensitivity assay, and established cardiovascular risk 
factors such as blood pressure and lipid levels, as well as resting heart rate, waist/hip ratio 
and daily hours of sleep.  Unexpected negative associations were found with total 
cholesterol and triglyceride levels, contrary to what was expected.  A significant positive 
association, not explained by physical activity or infection status, was found with resting 
heart rate.  Further study is warranted. 
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BACKGROUND 
CRP: General Information 
 C-reactive protein (CRP) is one of a class of proteins known as pentraxins, and 
the CRP molecule is made up of five identical subunits arranged in a ring shape (Mazer 
and Rabbani, 2004).  See Figure 1 below for CRP structure.   
 
 
 
 
 
 
  Figure 1:  Molecular Structure of CRP (Greenhough and Shrive, 2004). 
 
Each subunit has a weight of 23 kilodaltons (Ridker, 2003).  It was discovered in 
1930 and named “C-reactive protein” because it reacts with the C-polysaccharide on 
pneumococci (Gabay and Kushner, 1999).  CRP is an acute-phase protein whose levels 
in serum are elevated by inflammation, infection and tissue injury (Koenig et al., 1999).  
During an acute inflammatory event such as an infection, serum CRP levels can increase 
by more than a hundred fold, and then return to baseline level within about two weeks, 
as seen in Figure 2 below (Gabay and Kushner, 1999).  
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CRP is mainly produced in the liver but has recently been found to be produced 
by some cells in atherosclerotic plaque as well (Mazer and Rabbani, 2004).  In the liver, 
CRP is secreted in response to stimulation by IL-6 and IL-1 and, in the case of a 
bacterial infection, its function is to opsonize bacteria for phagocytosis by macrophages 
(by binding to phosphocholine in the cell membranes) as well as activate the 
complement cascade to lyse the bacterial cells (Janeway and Travers, 1994).  In addition, 
CRP binds cell debris resulting from tissue damage and therefore appears to play a role 
in the “clean-up” following such damage (Mazer and Rabbani, 2004).   
 
Relationship between CRP and Cardiovascular Disease 
 It is now generally believed that inflammation plays a major role in the 
development and progression of atherosclerosis.  Many observational studies have shown 
that higher levels of CRP are directly associated with increased risk of myocardial 
Figure 2.  Characteristic Patterns of 
Change in Plasma Concentrations of 
Some Acute-Phase Proteins after a 
Moderate Inflammatory Stimulus.    
 (Gabay and Kushner, 1999). 
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infarction (MI) and other adverse cardiovascular events.  This increased risk appears to 
be independent of other risk factors such as lipid levels (Ridker, 2003).  In one study 
(Ridker et al., 1998), the combination of CRP levels with total cholesterol and HDL was 
found to predict first MI in initially healthy men, better than the lipid measures alone.  
This case-control study used data from the Physicians’ Health Study, comparing baseline 
CRP and cholesterol levels in 245 subjects who were healthy at the beginning of the 
study, but later had MI’s, with those from 372 controls who did not have MI’s.  Another 
study (Ridker et al., 2003) examined the relationship of CRP levels, the metabolic 
syndrome and cardiovascular events among 14, 719 participants in the Women’s Health 
Study (the women were 45 years and older, and apparently healthy) and found that CRP 
levels added to the predictive value of the metabolic syndrome and its components for 
cardiovascular events.  Previously, Ridker and colleagues used data from the Women’s 
Health Study to suggest that CRP levels may in fact be better than LDL cholesterol levels 
for prediction of cardiovascular events, but that even greater predictive value is obtained 
by using both CRP and LDL measurements (Ridker et al., 2002).  The MONICA 
Augsburg Cohort Study (Koenig et al., 1999) followed 936 healthy men ages 45 to 64 for 
eight years to determine the association between CRP levels and the prevalence of first 
coronary events.  This study showed CRP levels and the incidence of cardiovascular 
events to be strongly correlated.  It has also been observed that patients with unstable 
angina who also have high CRP levels are more likely to have additional adverse 
coronary events than unstable angina patients without elevated CRP (Mazer and Rabbani, 
2004).  Finally, a correlation has been found between elevated CRP levels in heart 
transplant patients and transplant-associated coronary artery disease (coronary 
 8
atherosclerosis in the transplanted heart), which is a major cause of transplant failure 
aside from that caused by rejection (Mazer and Rabbani, 2004). 
 
Hypothesized Mechanisms for the Relationship between CRP and Cardiovascular 
Disease 
 
 Although it appears reasonably well established that CRP is a marker of 
cardiovascular risk, the specific reason for this relationship is not clear.  It is known that 
atherosclerotic plaques in various stages of development contain CRP, and also often 
contain monocytes and macrophages in the same areas where the CRP is found (Mazer 
and Rabbani, 2004).  CRP in the artery wall appears to enhance levels of monocyte 
chemoattractant protein-1 (MCP-1), which, as the name implies, attracts monocytes 
(which differentiate into macrophages) to the area, leading to their accumulation where 
they can contribute to plaque formation (Mazer and Rabbani, 2004).  It has also been 
demonstrated that it may be the monomeric subunits of CRP, rather than the entire CRP 
pentamer, that are responsible for raising levels of MCP-1; this indicates that CRP must 
dissociate in order to contribute to inflammation in the endothelium (Khreiss et al., 2004).  
If this is the case, there could be mutations in the CRP gene that would cause the 
pentamer to dissociate more easily, and such mutations could potentially increase a 
person’s risk of atherosclerosis.  Experiments have also shown that endothelial cells 
treated with CRP in vitro decrease their production of nitric oxide (NO), which is an 
important mediator of vasodilation; one of the first pathological changes in an artery 
developing atherosclerosis is a decrease in the capacity for such vasodilation (Mazer and 
Rabbani, 2004).    Another experiment (Zwaka et al., 2001) showed that as long as serum 
is present, macrophages in vitro take up, by phagocytosis, LDL that has been incubated 
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with CRP but do not phagocytize LDL alone or CRP alone.  This suggests that CRP 
opsonizes LDL for macrophages, and that this may be a mechanism for the formation of 
foam cells during the development of atherosclerosis.  Foam cells are formed when 
macrophages in the arterial wall take up modified lipoproteins and lipids (Willerson and 
Ridker, 2004); these cells play a major role in the development of atherosclerotic plaques.  
The findings of this experiment may also help to explain why CRP and LDL levels 
together give the greatest predictive value of future MI, as opposed to LDL alone or CRP 
alone.  In addition, exposure to CRP appears to affect vascular smooth muscle cells, 
causing them to proliferate and move into the space under the endothelium, which could 
also contribute to arterial blockage (Mazer and Rabbani, 2004).  All of the above findings 
suggest that CRP may be actively involved in causing atherosclerosis, as opposed to 
simply being a passive marker of cardiovascular disease risk. 
 
CRP and Blood Lipid Profile 
 Findings of previous studies examining the association of CRP levels with 
cholesterol and triglyceride levels have been somewhat mixed—some have found 
relationships, while others have not, and still others have found correlations with some 
components of the lipid profile but not others.  The most consistent finding was that CRP 
levels showed an inverse association with HDL cholesterol levels, while findings of 
correlation between CRP levels and LDL cholesterol levels were the least consistent.  
These findings are summarized below in Table 1.  In all of these studies, however, the 
analysis of relationships between CRP and blood lipid profiles was cross-sectional. This 
means that for each subject/patient, measurements were only made at one time point 
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rather than at multiple time points within a given period, so comparisons can only be 
made between subjects, not within subjects.  Longitudinal data, on the other hand, allow 
comparisons within subjects because measurements are taken at multiple time points for 
each patient.  The present study uses longitudinal data, so it is possible to make 
comparisons both between and within subjects.   In addition, in this project it was 
possible to control for many more possible confounders than in some of the previous 
studies.   
 
Table 1:  Summary of Studies Examining Relationship Between CRP and Lipid 
Profile 
Reference Study Design Population Sample Size Total chol. LDL HDL Triglycerides 
Choi et al., 
2004 
Cross-
sectional 
South Korean adults, separated 
into hypertensive (n=122) and 
normotensive (n=64); 
excluding those with overt 
cardiac disease, serum 
creatinine >150M or the 
presence of other systemic 
diseases 
0 0 - + 
Cook et 
al., 2000 
Cross 
sectional 
699 children from 10 towns in 
England and Wales, ages 9-11 
(364 boys and 335 girls) 
0 0 - 0 
Ford et 
al., 2004 
Cross 
sectional 
2205 US women 20 years or 
older, supposedly 
representative sample 
+ NA NA + 
Frohlich et 
al., 2000 
Population
-based 
cross-
sectional 
Adults ages 18-89 years in 
former West Germany, 
excluding those with acute 
illnesses; n=1703 total 
+ NA - + 
Laaksonen 
et al., 
2004 
Cross 
sectional 
analysis at 
baseline 
680 middle-aged Finnish men NA + - + 
Lambert et 
al., 2004 
School-
based 
cross-
sectional 
survey 
2224 children/adolescents ages 
9, 13 and 16 in Québec, Canada NA NA - + 
Mendall et 
al., 1996 
Cross 
sectional 
303 men aged 50-69 years in 
London, UK + + - + 
Retterstol 
et al, 2003 
Population
-based 
twin study 
Healthy Norwegian 
monozygotic twins (68 male 
pairs and 87 female pairs) ages 
38-57 years 
0 0 - + 
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Saito et 
al., 2003 
Cross-
sectional 
Japanese adults ages 30-79 who 
entered hospitalized health-
check program (n=566 for CRP 
analysis) 
0 NA - + 
Schillaci et 
al., 2003 
Cross 
sectional 
135 newly diagnosed, never-
treated hypertensive patients 
and 40 normotensive matched 
controls; no evidence of 
inflammation in the past month 
+ + NA + 
Strand-
berg and 
Tilvis, 
2000 
Population
-based 
cross-
sectional 
3 elderly cohorts aged 75, 80 
and 85 years from Helsinki 
Ageing Study; n=455 
not clear--
highest TC 
group had 
lower CRP—
possibly due 
to HDL 
NA - 0 
Vikram et 
al., 2003 
Cross 
sectional 
377 healthy adolescents and 
young adults aged 14-25 years 
(331 male and 46 female) in 
urban North India, excluding 
smokers and anyone who had 
an acute illness in the past 6 
months 
0 0 0 0 
Williams 
et al., 
2004 
Cross-
sectional 
822 men and women at the age 
of 26 years + NA - + 
Wu et al., 
2003 
Cross 
sectional 
835 children (410 boys and 435 
girls) aged 12-16 years in 
Taiwan 
0 0 - + (in boys) 
*  + denotes positive correlation; - denotes inverse correlation; 0 denotes lack of correlation, and NA 
indicates that the variable was not studied. 
 
CRP and Blood Pressure  
 While many studies have found positive associations between CRP and blood 
pressure (especially systolic pressure), some have found no correlation.  In the sleep-
deprivation experiments (Meier-Ewert et al., 2004), a positive correlation was observed 
between CRP and both systolic and diastolic blood pressure.  A number of observational 
studies, including two of hypertensive and normotensive adults in South Korea (Sung et 
al., 2003; Choi et al., 2004), as well as three others (Retterstol et al., 2003; Saito et al., 
2003; Laaksonen et al., 2004) also found positive associations between CRP and both 
systolic and diastolic blood pressure.  A study of elderly men and women without 
cardiovascular disease or diabetes found no correlation of CRP with either systolic or 
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diastolic blood pressure (Barbieri et al., 2003).  Similar results were reported in a study of 
men ages 50-69 (Mendall et al., 1996), as well as a study of children ages 9-11 (Cook et 
al., 2000).  Three studies found associations between CRP and systolic blood pressure, 
but no correlation with diastolic pressure.  These include a study of US women ages 20 
and over (Ford et al., 2004), a study of ischemic stroke patients (Di Napoli and Papa, 
2003), and a study of hypertensive patients and matched normotensive controls (Schillaci 
et al., 2003).  Another study found a relationship between CRP and systolic blood 
pressure, but this was no longer significant after adjustment for body mass index (BMI) 
(Lambert et al., 2004).  One group of researchers found no relationship between CRP 
levels and diastolic blood pressure, but their findings with systolic blood pressure were 
unique and interesting.  The correlation between CRP and systolic blood pressure was 
positive in women, but negative in men (Williams et al., 2004)—no other study had 
found a negative relationship between CRP and either blood pressure component.  Such a 
correlation does not seem to make biological sense, considering the experimental 
evidence that CRP can lead to a decrease in nitric oxide production and thus a lack of 
vasodilation.  These studies (with the exception of the sleep-deprivation experiments) 
were all cross-sectional in design; longitudinal data are lacking.  Below is a table 
summarizing the findings. 
Table 2:  Summary of Studies Examining Relationship between CRP and Blood 
Pressure 
Reference Study Design Population Sample Size Systolic BP 
Diastolic 
BP 
Barbieri et al., 
2003 Cross-sectional 
Elderly, excluding those with 
diabetes, cardiovascular disease, and 
taking drugs that affect BP, glucose 
metabolism and IL activity 
0 0 
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Choi et al., 2004 Cross-sectional 
South Korean adults, separated into 
hypertensive (n=122) and 
normotensive (n=64); excluding 
those with overt cardiac disease, 
serum creatinine >150M or the 
presence of other systemic diseases 
+ + 
Cook et al., 2000 Cross sectional 
699 children from 10 towns in 
England and Wales, ages 9-11 (364 
boys and 335 girls) 
0 0 
Di Napoli and 
Papa, 2003 Cross sectional 
535 first-ever ischemic stroke 
patients + 
0 when 
adjusted 
for other 
BP 
component
s 
Ford et al., 2004 Cross sectional 2205 US women 20 years or older, supposedly representative sample + 0 
Laaksonen et al., 
2004 
Population-based 
cohort study 680 middle-aged Finnish men + + 
Lambert et al., 
2004 
School-based 
cross-sectional 
survey 
2224 children/adolescents ages 9, 13 
and 16 in Québec, Canada 
0 after 
adjustment 
for BMI 
NA 
Meier-Ewert et 
al., 2004 
2 separate 
experiments 
Healthy adults ages 22-38; 10 for 
each experiment (exp. 1 was all men; 
2 was 6 men and 4 women) 
+ + 
Mendall et al., 
1996 Cross sectional 
303 men aged 50-69 years in 
London, UK 0 0 
Retterstol et al., 
2003 
Population-based 
twin study 
Healthy Norwegian monozygotic 
twins (68 male pairs and 87 female 
pairs) ages 38-57 years 
+ + 
Saito et al., 2003 Cross-sectional 
Japanese adults ages 30-79 who 
entered hospitalized health-check 
program (n=566 for CRP analysis) 
+ + 
Schillaci et al., 
2003 Cross sectional 
135 newly diagnosed, never-treated 
hypertensive patients and 40 
normotensive matched controls; no 
evidence of inflammation in the past 
month 
+ 0 
Sung et al., 2003 Cross-sectional 
South Korean adults without acute 
inflammatory disease; 4813 men and 
3534 women; divided into 
hypertensive and non-hypertensive 
+ + 
Williams et al., 
2004 Cross-sectional 
822 men and women at the age of 26 
years 
- in men; + 
in women 0 
* + denotes positive association; - denotes inverse association and 0 denotes no association.  NA 
indicates that the variable was not studied. 
 
 
CRP and Waist/Hip Ratio 
 Only a few studies have examined the association between CRP and waist-hip 
ratio, and there is agreement between them; however, they have all been cross-sectional 
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and therefore do not show what happens to CRP levels if there is a change in abdominal 
adiposity over time.  Four studies found a positive correlation between waist-hip ratio and 
CRP levels (Rexrode et al., 2003; Vikram et al., 2003; Wu et al., 2003; Laaksonen et al., 
2004).  In addition, Ford et al. (2004) as well as Williams et al. (2004) found a positive 
correlation between CRP and waist circumference, but did not measure waist-hip ratio.  
This method raises the possibility of confounding due to differences in overall body size, 
which may result in larger or smaller waist circumferences but not necessarily different 
waist/hip ratios. 
 
 
CRP and Sleep Deprivation 
 Only one study to date has examined the relationship of CRP levels to sleep 
deprivation (Meier-Ewert et al., 2004).  In this experimental study, both acute total sleep 
deprivation and short-term partial sleep deprivation were examined, with 10 subjects in 
each experiment.  CRP levels increased with sleep deprivation in both experiments, 
suggesting a causal relationship between sleep deprivation and higher CRP levels.  See 
Figure 3 below.  However, no previous studies have examined the relationship of sleep 
and CRP levels in a free-living population such as the one followed in the study that 
generated the database used in this project.  This type of information may be useful in 
determining whether CRP levels appear to be affected by mild or moderate chronic sleep 
deprivation in “real life”, though from an observational study it is not possible to infer 
causal associations.  
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Figure 3:  Effect of Partial Sleep Deprivation on CRP Levels.   Data were log-transformed before 
analysis. For ease of interpretation, the mean values ± SEM were transformed from the log scale back to 
the usual scale (mg/dl) in subjects undergoing 10 consecutive days of short-term partial sleep deprivation (n 
= 4, squares) and control subjects (n = 5, diamonds). Significance of difference in change from baseline to 
day 10 between groups (p < 0.08 for interaction) by mixed-models analysis of variance on log-transformed 
data: the change from baseline to day 10 for the short-term partial sleep deprivation group was significant 
(p < 0.05), whereas the change from baseline to day 10 in the control subjects was not significant (p = 
0.72). The horizontal lines indicate risk boundaries (mild to highest) of C-reactive protein (CRP) quintiles 
derived from analysis of >5,000 apparently healthy Americans.   (Meier-Ewert et al., 2004) 
 
CRP and Resting Heart Rate 
 
 A positive relationship between CRP levels and resting heart rate was found in a 
study of children in England and Wales (Cook et al., 2000).  In the sleep deprivation 
study (Meier-Ewert et al., 2004), a positive correlation was also found between CRP and 
heart rate in the short-term partial sleep deprivation experiment; in the acute total sleep 
deprivation experiment both increased as well.  However, this relationship has not 
previously been well studied, and the current project, using longitudinal data, yields 
additional information.  It was also possible, to some degree, to control for the use of 
medications that can affect heart rate, such as beta blockers.  In addition, the possibility 
was considered that any correlation could stem partly or wholly from deconditioning in 
people with higher resting heart rates (i.e. people may have higher resting heart rates 
because they are not well conditioned, and such deconditioning could potentially 
contribute to higher CRP levels), and in this study it was possible to control for physical 
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activity in order to better determine whether this could be a plausible explanation.  
Infection history could be another contributing factor, as heart rates tend to increase 
during infections; it was possible to control for this to some degree in this project. 
 
Background on SEASONS study 
 The Seasonal Variation of Blood Cholesterol Levels (SEASONS) study was a 
prospective study intended to examine seasonal changes in blood lipid levels and relevant 
covariates (Merriam et al., 1999).  Longitudinal data were collected from a cohort of 
healthy adults in Central Massachusetts from 1994 through 1998, including lipid levels, 
dietary data, physical activity and many other measures.  In addition, blood samples from 
most participants were stored and analyzed later for CRP levels; these data were used in 
this project, along with the data previously gathered.  The SEASONS study was based at 
the University of Massachusetts Medical School. 
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PROJECT PURPOSE 
 The purpose of the “Determinants of C-Reactive Protein” study at the University 
of Massachusetts Medical School was to more clearly define the factors that affect C-
reactive protein levels in healthy adults by analyzing longitudinal data collected during 
the SEASONS study (described briefly in Background and in more depth in Methods 
section) in combination with measurements of CRP levels, using a high-sensitivity assay, 
in stored blood samples from 617 SEASONS study participants.  These factors include 
body mass index (BMI), dietary factors, physical activity, and psychological factors such 
as depression.   
 The purpose of my specific part of the study was to examine the longitudinal and 
cross-sectional relationships between CRP levels and the following factors:  blood lipid 
levels, blood pressure, resting heart rate, waist/hip ratio, and daily hours of sleep.  The 
completeness of the data set allowed adjustment for possible confounders such as BMI, 
physical activity, and dietary factors, as well as infection history and medication use.  
Although other studies had looked at the relation between CRP and some of these factors, 
they were all cross-sectional in design (with the exception of the experimental sleep-
deprivation study) and therefore provided no information about within-subject effects.  In 
addition, there was disagreement on these relationships in some of the previously 
published studies, likely due in part to differences in study populations.  Special attention 
was paid to potential correlations between serum CRP levels and resting heart rate since 
this relationship had not been previously well studied. 
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METHODS 
SEASONS study and database description 
 The Seasonal Variation of Blood Cholesterol (SEASONS) study was designed to 
describe seasonal changes in blood lipids in the general adult population and to attempt to 
explain possible causes of such changes.  There were 641 healthy adults in the study 
cohort.  They ranged in age from 20 to 70 years, were predominantly white and both 
genders were about equally represented (Merriam et al., 1999).  Subjects were required to 
be literate in English and not be on any lipid-lowering drugs or on a diet to lose weight or 
lower lipids.  In addition, subjects could not be included if they had any potentially fatal 
illness, any condition that could cause elevations in lipid levels, a history of cancer 
(except for skin cancers other than melanoma) less than 5 years ago, or any psychiatric or 
other problems that could interfere with their completing the study (Merriam et al., 1999).   
 Major factors examined in the SEASONS study included blood lipid levels, 
dietary intake, physical activity (sleep information was collected along with this), light 
exposure, psychosocial factors and anthropometric measurements.  Psychosocial factors 
included anxiety and depression.  In addition, information was collected on subjects’ use 
of medications at baseline and their infection history each quarter.  Anthropometric 
measures used were height, weight, body mass index (BMI), waist circumference, hip 
circumference and waist/hip ratio (Merriam et al., 1999).   
 Data were collected using a variety of methods.  Questionnaires were used to 
gather demographic and health information at baseline, as well as to assess psychosocial 
factors such as depression and anxiety (Merriam et al., 1999).  At baseline, participants 
were also asked to list any medications they were taking.   Subjects completed the 
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depression and anxiety questionnaires five times; once at baseline and then every 13 
weeks.  At the same 13-week intervals, clinic visits were conducted in which subjects 
were weighed and asked questions about their recent health history, including infection 
history.  Before each visit, subjects were asked to use a home blood pressure monitor to 
measure their blood pressure and pulse, then bring this information to the appointment.  
This was done before 9:30 in the morning, after sitting for 5 minutes but after the subjects 
had been awake for a half hour or more.  Telephone interviews were used to collect 
dietary intake information around the time of each clinic visit; subjects were asked to 
recall what and how much they ate over the past 24 hours, as well as provide information 
on their physical activity during the same period; this was called a 24-hour recall, or 
24HR.  Glycemic index (GI), a measurement of carbohydrate quality, was determined 
from the 24HRs using published tables (Foster-Powell et al., 2002; Brand-Miller et al., 
2003). Glycemic load (GL) (GI of a food x the amount of carbohydrate eaten)/ 100) was 
also calculated, as has been previously reported (Ma et al., 2005).  The 24-hour physical 
activity data collection methodology was adapted from methodology developed for a 
seven-day recall of physical activity (Sallis et al., 1985), and was administered together 
with the diet recall as mentioned above. Methods described by Ainsworth and colleagues 
(Ainsworth et al., 2000) were used to estimate total daily energy expenditure in metabolic 
equivalent task hours (MET-hour) based on the reported time spent at each activity type 
and intensity level (Matthews et al., 2000; Matthews et al., 2001; Matthews et al., 2001). 
This methodology has been validated (Matthews et al., 2000).  Waist/hip ratio was 
measured at the first and last visits.  For lipid measurements, 12-hour-fasting venous 
blood samples were drawn around the time of each clinic visit.   The samples were drawn 
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between 7:00 and 10:00 am to avoid any confounding due to circadian fluctuations in 
lipid levels, and to make 12-hour fasting tests feasible.  Levels of total cholesterol, HDL, 
and triglycerides were tested; assays were performed in a Centers for Disease Control 
standardized laboratory (Merriam et al., 1999).  LDL cholesterol levels were calculated 
using the standard Friedewald formula (see below) if triglyceride levels were less than 
400 mg/dl.   
Friedewald formula for calculating LDL cholesterol levels:  total cholesterol = HDL + 
LDL + 0.2(triglycerides); all measurements are in mg/dl. 
Sample storage conditions and CRP assay 
 At the time of collection, serum aliquots were placed in individual tubes for 
analysis and were frozen to -80 degrees Celsius.  Aliquots not used for the original lipid 
analyses or other tests during the original study remained frozen at this temperature until 
they were needed for the CRP analysis.  Because the SEASONS study began at the end 
of 1994, some of these samples were in frozen storage for nearly ten years.  However, 
this does not appear to pose a problem for the accuracy of the measurements.  A study of 
extended storage showed no significant changes in CRP concentrations in plasma and 
serum samples that were frozen at -70 degrees Celsius for over 20 years (Ledue and 
Rifai, 2003); this indicates that CRP is very stable during long periods of storage and 
therefore the fact that these samples were stored for up to ten years does not diminish the 
accuracy of the results. 
 To determine CRP levels, a high-sensitivity immunoturbidimetric assay was 
carried out.  The equipment used included a Hitachi 917 analyzer from Roche 
Diagnostics in Indianapolis, IN.  Reagents and calibrators were supplied by Denka Seiken 
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in Niigata, Japan.  In this assay, an anti-CRP antibody, which has been sensitized to latex 
particles, binds CRP in the sample and causes agglutination.  Light scattering is increased 
as a result of the agglutination, and this scattering is measured by a spectrophotometer.  
The change in light scattering is directly proportional to the CRP concentration of the 
sample; the assay can detect CRP concentrations as low as 0.03 mg/l.  All blood analyses 
for CRP were carried out in the laboratory of Dr. Nader Rifai at Children’s Hospital, 
Boston. 
Data analysis  
 The statistics software package used for all analyses was Stata 8 SE for Windows 
(Stata Corporation; College Station, TX).  This package can be used to perform a wide 
variety of statistical tests, as well as plotting regression lines and other results, and also 
allows new variables to be easily generated from existing variables in the data set.  The 
main functions used were descriptive statistics and plots, regression analyses (bivariate 
and stepwise/multivariate), and longitudinal regression. 
 In addition to the general exclusion criteria for the SEASONS study (discussed 
under “SEASONS study and database description”), the original plan for this project 
called for specific exclusion criteria due to factors that would be unlikely to affect lipid 
levels and other measurements examined in the original study but could affect CRP 
results and/or other variables being examined in the CRP project.  However, this was not 
feasible due to the way the relevant information was collected.  For example, subjects 
were going to be excluded from the entire analysis if they were taking any anti-
inflammatory medications, as these are known to lower CRP levels.  Subjects who were 
taking beta blockers would have been excluded from the analyses that include heart rate 
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and blood pressure, as beta blockers lower these and may also lower CRP levels; the 
concern was that this could lead to confounding.  Finally, subjects who had recently had 
an infection or other inflammatory process were going to be excluded.  The problem lies 
in the fact that when the SEASONS study was originally conducted, there was no plan for 
the CRP study; the idea for this study came later.  Therefore, data on medication use were 
only collected at baseline rather than at each clinic visit; using this information would 
have required the assumption that all patients who were taking medication at baseline 
continued taking it throughout the study, and vice versa.  In addition, the only 
information collected on infections or other illnesses was a section in the quarterly 
questionnaire asking if the patient had had a cold, flu, allergy or other illness within the 
past three months.  This is not a very useful measurement of current infection status, as 
CRP levels return to normal within two weeks after an illness (Gabay and Kushner, 
1999), and therefore it was decided not to use this information or the medication data to 
exclude patients from the analysis.  Instead, the longitudinal analysis simply controlled 
for infection history and beta-blocker use (did not control for anti-inflammatory 
medications, as these are often taken on a short-term basis). 
 
Statistical methods 
Introduction 
 Descriptive statistics, including mean, standard deviation and percentiles, were 
first tabulated for all CRP values in the entire dataset.  Each patient in the study had up to 
five clinic visits, which included blood draws.  Some patients had more than one CRP 
measurement for a given clinic visit, due to having more than one stored vial of blood 
 23
available from that visit for analysis.  When this occurred, all values for that time point 
were averaged to arrive at the overall CRP value for that visit.  The distribution of the 
number of CRP measurements per patient was then determined, to see how many had all 
five measurements and how many had fewer.  Patients with at least one measurement 
were included in the initial cross-sectional analyses used for building the model, but 
excluded from the longitudinal analyses.  For the cross-sectional analysis, the mean of all 
CRP values was computed for each patient in order to have a single average value per 
patient.  A histogram was then made of these mean CRP values, and the distribution was 
highly positively skewed; natural-log transformation made the distribution sufficiently 
normal to permit the use of linear regression analysis (see figures 4 and 5 in Results 
section).  Mean values were computed for each patient for all other variables in the 
analysis as well (lipids, BMI, dietary intakes etc.).  It was necessary to create a separate 
dataset for the cross-sectional analyses, with the mean values of each variable, in order to 
avoid having multiple measurements in the data set for each patient. 
Sample description 
Baseline sample characteristics, as well as relevant clinical, physiological, 
psychological and lifestyle characteristics, were described as mean (SD) for continuous 
variables, and as n (%) for categorical variables. 
Cross-sectional model building 
 Exploratory graphical techniques (locally weighted regression) were used to 
determine the bivariate relationship of natural-log-transformed CRP with all possible 
predictors considered. Associations were found to be approximately linear. Therefore, 
linear regression was used for all analyses.  The first step was to perform crude bivariate 
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regression analyses with natural-log-transformed CRP (mean value) as the dependent 
variable and each possible covariate or variable of interest as the independent variable.  
This allowed determination of factors that were related to CRP levels if nothing else was 
controlled for.  These crude analyses were carried out for the overall study group as well 
as stratified by BMI classification (separating normal, overweight and obese), since BMI 
is a known strong predictor of CRP levels and there was a reasonable sample size in each 
category.  Any variables, other than the variables of interest, for which the p value was 
less than or equal to 0.20 in the crude analysis were then put into a stepwise regression 
(multiple independent variables) with log-transformed CRP again as the dependent 
variable.  Any of these variables that remained in the model after the stepwise regression 
(p value less than or equal to 0.20) were put into the final model for CRP.  This model 
was then used for the longitudinal analysis.  These steps (from crude bivariate analysis to 
model building) were performed for the overall study group, and again with patients 
stratified by BMI category.  In the BMI stratified analysis, BMI was still treated as a 
covariate within each category, to control for residual effects. 
Longitudinal analysis 
 Linear mixed models were used for longitudinal analysis, making the distinction 
between cross-sectional (between-subject) and longitudinal (change over time within 
subjects) effects of the risk factors of interest and other predictors.  The “cross-sectional 
effect” refers to the average value of a given variable (for example, LDL level) for a 
particular subject, while “longitudinal effect” refers to the difference from this average at 
a given time point (Ma et al., 2005).  The longitudinal analysis included only subjects 
with two or more CRP measurements.   Subject and time point (quarter) were treated as 
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random effects, while the cross-sectional and longitudinal effects of the various 
predictors were considered fixed effects.  Both unadjusted and adjusted analyses were 
performed, for the overall study group and stratified by BMI classification as in the cross-
sectional model building.  The adjusted analysis controlled for covariates found to be 
related to CRP levels in the original cross-sectional model building.  The results of this 
adjusted analysis are considered to be the final results. 
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RESULTS 
 
Demographic information 
 
 Six hundred and seventeen subjects (96% of the SEASONS subjects) with at least 
one CRP measurement were included in the SEASONS CRP data analysis.  Both sexes 
were equally represented in this cohort.  The patients in the study were predominantly 
white, married and employed full time.  See table 3 below for detailed demographic 
information. 
Table 3:  Demographics of SEASONS CRP study cohort (n = 617) 
 
 n (%) or mean (SD) 
Age (years) 47.33 (12.32) 
Gender:                                 Male 318 (51.54%) 
Female 299 (48.46%) 
Race:                               White 510 (85%) 
Non-white 90 (15%) 
Education:                   High school 
                                     or less 
154 (25.08%) 
Some college 
or associate’s degree
227 (36.97%) 
Bachelor’s degree or more 233 (37.95%) 
Employment:                   Full-time 416 (67.64%) 
Part-time 91 (14.80%) 
Unemployed or retired 108 (17.56%) 
Marital status:               Married or 
                            living with partner 
470 (76.42%) 
Not living with a partner 145 (23.58%) 
 
Baseline characteristics of study cohort 
 The majority of patients in the study were overweight or obese, with the average 
BMI of 27.28 in the “overweight” range.  Of the 602 subjects for whom smoking status 
information was available, 82% were non-smokers.  The average total cholesterol level of 
218 mg/dl was in the borderline-high range, although average LDL, HDL and 
triglycerides were all within the acceptable range.  Average systolic and diastolic blood 
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pressures were also within normal range.  The average CRP level of 2.43 mg/l falls 
within American Heart Association criteria for ”average” cardiac risk (Pearson et al., 
2003). 
Table 4:  Baseline clinical, physiological, psychological and lifestyle characteristics 
of SEASONS CRP study cohort (n = 617) 
 
 
 
 
 
 Mean (SD) Median Range 
BMI (kg/m ^2) 27.28 (5.42) 26.69 16.83-56.70 
Waist/hip ratio 0.859 (0.092) 0.862 0.657-1.20 
Total cholesterol (mg/dl) 218 (43.72) 213 75-419 
LDL cholesterol (mg/dl) 143 (38.70) 140 18-331 
HDL cholesterol (mg/dl) 47 (12.75) 46 22-108 
Triglycerides (mg/dl) 140 (118.17) 113.5 26-1534 
Systolic blood pressure (mm Hg) 120 (18.80) 118 76-224 
Diastolic blood pressure (mm Hg) 77 (11.26) 76 51-119 
Resting heart rate (beats/min) 69 (11.73) 68 37-113 
CRP (mg/l) 2.43 (5.12) 1.10 0.02-62.79 
Leisure physical activity (MET-
hrs/day) 
1.99 (3.09) 0.833 0-26.00 
Daily hours of sleep 7.12 (1.13) 7.17 2.83-11.00 
Beck depression score 6.26 (5.57) 5 0-28 
Beck anxiety score 4.40 (5.84) 3 0-49 
Daily caloric intake (kcal) 1951 (673) 1840 769-5813 
Daily % of calories from fat 31.38 (7.35) 31.40 7.78-58.19 
Daily % of calories from sat. fat 11.22 (3.42) 11.13 2.10-21.56 
Daily % of calories from carbohydrate 51.51 (8.86) 51.46 26.89-79.56 
Daily % of calories from protein 15.97 (3.46) 15.64 6.38-29.25 
Daily dietary glycemic index 83.43 (7.06) 83.65 52.94-104.59 
Daily dietary glycemic load 196.11 (82.30) 183.21 40.19-1084.81 
Daily total fiber intake (g) 15.90 (6.97) 14.48 3.25-59.04 
Daily soluble fiber intake (g) 5.73 (2.42) 5.27 1.06-16.42 
Daily water intake (g) 1874.99 
(680.22) 
1785.48 196.82-
5371.92 
Daily alcohol intake (g) 7.68 (15.67) 0.177 0-148.78 
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Distribution of CRP levels 
 Subjects’ mean CRP levels (including subjects with only one measurement) 
showed a non-Gaussian distribution; they were heavily skewed to the right (figure 4); p < 
0.001 for Shapiro-Francia normality test, where a p value less than 0.05 indicates a non-
Gaussian distribution.  Natural-log transformation normalized the CRP data (figure 5).  
When the Shapiro-Francia test was performed on the log-transformed data, the p value 
was 0.61, indicating a normal (Gaussian) distribution. 
Figure 4:  Histogram of patients’ mean CRP levels.  Note that the vast majority are under 10 mg/l. 
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Figure 5:  Histogram of natural-log transformed mean CRP levels.  Note that this is a reasonable 
approximation of a normal distribution. 
 
 
 The majority of patients had at least four of the five possible CRP measurements.  
74 patients had only one measurement.  See table 5 below for a summary of measurement 
frequency. 
Table 5:  Number of CRP measurements (out of a possible 5) for patients in study 
Measurements Frequency (number of 
patients) 
Percentage of study 
group 
Cumulative 
percentage 
5 227 35.4 35.4 
4 129 20.1 55.5 
3 108 16.9 72.4 
2 79 12.3 84.7 
1 74 11.5 96.2 
0 24 3.7 99.9 
*Did not add to exactly 100% due to rounding. 
Crude bivariate analyses 
 When linear regression was carried out between natural-log transformed mean 
CRP levels and individual physiological and lifestyle factors, many of the factors were 
found to be significantly related to CRP levels.  This was true both for the entire study 
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group and for the groups stratified by BMI classification (normal, overweight and obese).  
There were significant associations with many of the variables of interest (lipids, blood 
pressure, waist/hip ratio, and heart rate) in the entire group and in some of the BMI 
groups; however, no association was seen with daily sleep time in any group.  See tables 
6 and 7 below for detailed results of these analyses; table 6 is for the study group as a 
whole and table 7 is stratified by BMI classification.  Note that these analyses included 
patients with only one CRP measurement. 
Table 6:  Summary of preliminary crude bivariate analyses for entire group (n = 
617):  linear regression of CRP (average value for each patient) with other factors 
 
Variable Regression 
Coefficient 
(β) 
SE P value 
Age 0.015 0.004 < 0.001 
Gender:  Male -- -- -- 
Female -0.006 0.088 0.947 
Marital status:  Married or living with 
partner 
-0.073 0.104 0.481 
Not married or living with partner -- -- -- 
Education:  High school or less -- -- -- 
Associate’s degree or some college -0.313 0.112 0.005 
Bachelor’s degree or higher -0.527 0.111 < 0.005 
Employment:  Full time -- -- -- 
Part time 0.111 0.124 0.372 
Unemployed or retired 0.353 0.116 0.002 
Race:  White 0.110 0.124 0.378 
Non-white -- -- -- 
Smoking status:  Non-smoker -- -- -- 
Smoker 0.386 0.115 0.001      
BMI 0.095   0.007     <0 .001      
Leisure physical activity (MET-hrs/day) -0.100 0.022 <0 .001      
Caloric intake (kcal) -0.0001    0.0001     0.541     
% of calories from fat 0.028    0.007      <0 .001      
% of calories from sat. fat 0.056   0.015      <0 .001      
% of calories from non-sat. fat 0.041    0.012      0.001      
% of calories from carb. -0.025    0.006     <0 .001      
% of calories from protein 0.027    0.016      0.098     
Alcohol intake (g) 0.002    0.003      0.514     
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Total fiber intake (g) -0.027    0.008     <0 .001      
Water intake (g) 0.0001    0.0001      0.532     
Soluble fiber intake (g) -0.062   0.022     0.005     
Daily GI 0.013    0.009      0.139     
Daily GL -0.002    0.001     0.016     
Daily hrs of sleep -0.016    0.050     0.749     
Beck anxiety score 0.034    0.008      <0 .001      
Beck depression score 0.035   0.008      <0 .001      
Total cholesterol (mg/dl) 0.004     0.001      <0 .001      
LDL cholesterol (mg/dl) 0.004   0.001      0.001      
HDL cholesterol (mg/dl) -0.020    0.004     <0 .001      
Triglycerides (mg/dl) 0.002    0.0004      <0 .001      
Systolic BP(mm Hg) 0.018    0.003      <0 .001      
Diastolic BP (mm Hg) 0.031    0.005      <0 .001      
Heart rate (bpm) 0.020   0.004      <0 .001      
Waist/hip ratio 2.490    0.473      < 0.001      
P values in italics indicate significance; association was taken to be statistically significant if p <= 0.05.  -- 
indicates reference group for categorical variable. 
 
Table 7:  Bivariate regression analyses of the relation of log-transformed CRP with 
other factors, stratified by BMI category  
 Normal BMI (n = 
227) 
Overweight (n = 
243) 
Obese (n = 147) 
 Regression 
coefficient 
(SE) 
p Regression 
coefficient 
(SE) 
p Regression 
coefficient 
(SE) 
p 
Demographic 
factors: 
 
Age .023 (.005) <0.001 .010 (.005) 0.043 .0006 (.007) 0.924 
Gender:  Male -- -- -- -- -- -- 
Female -.110 (.134) 0.412 .128 (.128) 0.319 .471 (.157) 0.003 
Marital status:  
Married or 
living with 
partner 
-.046 (.148) 0.753 -.314 (.159) 0.049 .119 (.185) 0.522 
Not married or 
living with 
partner 
-- -- -- -- -- -- 
Education:  High 
school or less 
-- -- -- -- -- -- 
Associate’s 
degree or some 
college 
-.346 (.181) 0.057 -.131 (.169) 0.437 -.292 (.183) 0.113 
Bachelor’s 
degree or higher 
-.376 (.169) 0.027 -.236 (.171) 0.169 -.417 (.206) 0.044 
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Employment:  
Full time 
-- -- -- -- -- -- 
Part time .198 (.177) 0.266 .102 (.184) 0.580 .159 (.240) 0.508 
Unemployed or 
retired 
.341 (.188) 0.071   .385 (.164) 0.02 .068 (.200) 0.733 
Race:  White -.035 (.176) 0.842 .230 (.189) 0.223 .045 (.226) 0.843 
Non-white -- -- -- -- -- -- 
Physiological 
factors: 
 
BMI .090 (.037) 0.017 .074 (.045) 0.100 .069 (.016) <0.001
Waist/hip ratio 1.650 (.771) 0.033 .338 (.803) 0.674 -1.44 (.923) 0.120 
Total cholesterol 
(mg/dl) 
.005 (.002) 0.007 .002 (.002) 0.199 -.002 (.002) 0.399 
LDL cholesterol 
(mg/dl) 
.005 (.002) 0.006 .002 (.002) 0.338 -.002 (.003) 0.374 
HDL cholesterol 
(mg/dl) 
-.014 (.005) 0.007 -.005 (.006) 0.417 -.0001 
(.008) 
0.989 
Triglycerides 
(mg/dl) 
.002 (.001) 0.004 .001 (.001) 0.194 -.0003  
(.0005) 
0.588 
Systolic blood 
pressure (mm 
Hg) 
.012 (.004) 0.006 .004 (.004) 0.398 .005 (.006) 0.349 
Diastolic blood 
pressure (mm 
Hg) 
.023 (.008) 0.002 .004 (.007) 0.535 .003 (.011) 0.811 
Resting heart 
rate (bpm) 
.014 (.006) 0.026 .023 (.007) 0.001 .021 (.008) 0.010 
Lifestyle 
factors: 
 
Leisure physical 
activity (MET-
hrs/day) 
-0.067 
(.030) 
0.027 -0.060 
(.033) 
0.066 -0.089 
(.053) 
0.097 
Caloric intake 
(kcal) 
-.000025 
(.0001) 
0.823 -.0000378 
(.0001) 
0.730 -.0003 
(.0001) 
0.070 
% calories from 
non-saturated fat 
.024 (.018) 0.191 .012 (.017) 0.476 .021 (.024) 0.390 
% calories from 
saturated fat 
.029 (.023) 0.207 .023 (.022) 0.288 .032 (.032) 0.331 
% calories from 
carbohydrate 
-.022 (.008) 0.011 -.001 (.009) 0.906 -.015 (.012) 0.220 
% calories from 
protein 
.022 (.025) 0.365 -.006 (.023) 0.781 .027 (.032) 0.395 
Total fiber 
intake (g) 
-.020 (.010) 0.043   -.010 (.012) 0.399 -.034 (.016) 0.038 
Water intake (g) .0001 
(.0001) 
0.555 -.00005 
(.0001) 
0.626 .0001 
(.0001) 
0.663 
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Alcohol intake 
(g) 
.007 (.004) 0.095 -.003 (.005) 0.563 .001 (.006) 0.867 
Daily glycemic 
index (GI) 
.006 (.013) 0.657 .013 (.013) 0.344 .018 (.015) 0.229 
Daily glycemic 
load (GL) 
-.002 (.001) 0.111 -.0003 
(.001) 
0.744 -.003 (.001) 0.034 
Daily hours of 
sleep 
.030 (.072) 0.678 .002 (.073) 0.981 .015 (.091) 0.874 
Smoking status:  
smoker 
.357 (.161) 0.028 .687 (.164) <0.001 .256 (.230) 0.268 
Non-smoker -- -- -- -- -- -- 
Psychological 
factors: 
 
Beck anxiety 
score 
.021 (.014) 0.135 .025 (.015) 0.098 .026 (.011) 0.025 
Beck depression 
score 
.013 (.012) 0.277 .022 (.012) 0.069 .040 (.012) 0.001 
-- indicates reference group for categorical variable; italics indicate significance as in table 6. 
 
 
Longitudinal analyses 
Overall group 
 The following factors were in the predictive model for CRP levels in the overall 
cohort:  age, BMI, dietary protein percentage, Beck depression score, leisure physical 
activity and smoking status.  The analysis also controlled for recent infection history, as 
infection greatly increases CRP levels.  In analyses dealing with heart rate or blood 
pressure, adjustment was also made for beta blocker use, as beta blockers obviously 
affect heart rate and blood pressure and appear also to decrease CRP levels (Jenkins et 
al., 2002).  Cross-sectionally, diastolic blood pressure, heart rate and daily hours of sleep 
were positively associated with CRP levels in the adjusted analysis.  Longitudinally, total 
cholesterol and triglycerides showed an inverse association with CRP levels, and resting 
heart rate showed a positive association with CRP levels.  See table 8 for a summary.  
Unadjusted analyses are presented for comparison. 
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Table 8:  Association of lipids, BP, heart rate, WHR and daily sleep with natural-log 
transformed CRP levels, overall cohort 
 Unadjusted Adjusted* 
 Cross-sectional Longitudinal Cross-sectional  Longitudinal 
 β (SE) p β (SE) p β (SE) p β (SE) p 
Total 
cholesterol 
0.005 
(.001) 
< 
0.001
-0.003 
(0.001) 
0.002 0.0003 
(0.001) 
0.751 -0.004 
(0.001) 
0.001 
LDL 0.004 
(0.001) 
< 
0.001
-0.002 
(0.001) 
0.191 -0.0003 
(0.001) 
0.760 -0.002 
(0.001) 
0.082 
HDL -0.021 
(0.003) 
< 
0.001
-0.003 
(0.003) 
0.406 -0.003 
(0.003) 
0.335 -0.003 
(0.004) 
0.445 
Triglycerides 0.002 
(0.0003) 
< 
0.001
-0.001 
(0.0003)
0.001 0.0005 
(0.0003) 
0.175 -0.001 
(0.0003) 
0.003 
Systolic BP 0.022 
(0.003) 
< 
0.001
0.002 
(0.002) 
0.446 0.005 
(0.003) 
0.078 0.001 
(0.002) 
0.716 
Diastolic BP 0.044 
(0.005) 
< 
0.001
0.003 
(0.003) 
0.266 0.011 
(0.005) 
0.029 0.002 
(0.003) 
0.484 
Heart rate 0.023 
(0.004) 
< 
0.001
0.012 
(0.002) 
< 
0.001
0.018 
(0.004) 
< 
0.001 
0.013 
(0.003) 
< 
0.001 
Waist/hip 
ratio 
2.995 
(0.446) 
< 
0.001
1.440 
(0.987) 
0.145 0.234 
(0.444) 
0.597 1.152 
(1.043) 
0.269 
Daily sleep 
(hours) 
0.047 
(0.050) 
0.344 -0.014 
(0.022) 
0.508 0.105 
(0.044) 
0.018 0.002 
(0.023) 
0.923 
*Adjusted for age, BMI, dietary protein percentage, Beck depression score, leisure physical activity, smoking status, 
infection history and (for analyses dealing with heart rate and BP) beta blocker use. 
 
 A longitudinal analysis was also performed in which the group was stratified by 
gender (data not shown), to assess any differences between men and women in these 
associations.  From this analysis, it was found that the inverse longitudinal association of 
triglyceride levels with CRP levels was only present in men, while only the women 
showed a significant positive cross-sectional association between triglycerides and CRP.  
The positive cross-sectional association between diastolic blood pressure and CRP levels 
was found in the men and not the women.  Associations of CRP levels with total, HDL 
and LDL cholesterol, systolic blood pressure, resting heart rate and hours of sleep were 
similar between men and women.  In women, there was a strong positive cross-sectional 
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association between waist/hip ratio and CRP levels; no such association was found in 
men. 
Normal BMI 
 For subjects with normal BMI, the predictive model for CRP included age, BMI, 
dietary carbohydrate and non-saturated fat percentage, Beck anxiety score, leisure 
physical activity and smoking status.  Adjustment was also made for infection history and 
beta blocker use as in the analysis for the overall group.  Cross-sectionally, daily hours of 
sleep were positively associated with CRP levels.  Longitudinally, resting heart rate 
showed a positive association with CRP levels.  In addition, there was a trend toward a 
positive cross-sectional association of WHR with CRP levels.  See table 9 for a summary.  
This group included, in addition to subjects with normal BMI, 6 underweight subjects 
(BMI < 18.5).  However, this is a small percentage of the group and therefore should not 
affect the results. 
Table 9:  Association of lipids, BP, heart rate, WHR and daily sleep with natural-log 
transformed CRP levels, normal BMI subgroup 
 Unadjusted Adjusted* 
 Cross-
sectional  
Longitudinal Cross-sectional Longitudinal 
 β (SE) p β (SE) p β (SE) p β (SE) p 
Total 
cholesterol 
0.005 
(0.001) 
0.001 -0.004 
(0.002) 
0.050 -0.002 
(0.002) 
0.374 -0.003 
(0.002) 
0.177 
LDL 0.006 
(0.002) 
< 
0.001 
-0.003 
(0.002) 
0.191 -0.001 
(0.002) 
0.467 -0.002 
(0.002) 
0.442 
HDL -0.012 
(0.005) 
0.010 -0.005 
(0.006) 
0.355 -0.008 
(0.005) 
0.093 -0.002 
(0.006) 
0.728 
Triglycerides 0.002 
(0.001) 
0.004 -0.001 
(0.001) 
0.467 0.001 
(0.001) 
0.286 -0.001 
(0.001) 
0.301 
Systolic BP 0.014 
(0.004) 
< 
0.001 
0.003 
(0.004) 
0.539 0.004 
(0.005) 
0.361 0.001 
(0.004) 
0.817 
Diastolic BP 0.022 
(0.007) 
0.002 0.006 
(0.006) 
0.311 0.005 
(0.008) 
0.530 0.007 
(0.005) 
0.250 
Heart rate 0.011 
(0.006) 
0.047 0.012 
(0.005) 
0.007 0.007 
(0.006) 
0.239 0.012 
(0.005) 
0.013 
Waist/hip 2.542 < 1.490 0.525 1.307 0.076 2.184 0.352 
 36
ratio (0.611) 0.001 (2.344) (0.736) (2.347) 
Daily sleep 
(hours) 
0.086 
(0.064) 
0.181 -0.029 
(0.043) 
0.504 0.123 
(0.062) 
0.045 -0.006 
(0.043) 
0.882 
*Adjusted for age, BMI, dietary carbohydrate and non-saturated fat percentage, Beck anxiety score, leisure physical 
activity, smoking status, infection history and (for analyses dealing with heart rate and BP) beta blocker use. 
 
Overweight 
 
 In the subgroup of overweight subjects, the predictive model for CRP included 
age, Beck depression score, smoking status and alcohol drinking status; adjustment was 
also made for infection history and beta blocker use as in the other analyses.  Cross-
sectionally, heart rate and diastolic blood pressure showed a positive association with 
CRP levels.  Longitudinally, total cholesterol and triglycerides showed an inverse 
association with CRP levels; resting heart rate showed a positive association with CRP 
levels.  See table 10 for a summary. 
 
Table 10:  Association of lipids, BP, heart rate, WHR and daily sleep with natural-
log transformed CRP levels, overweight subgroup 
 Unadjusted Adjusted* 
 Cross-
sectional  
Longitudinal Cross-sectional Longitudinal 
 β (SE) p β (SE) p β (SE) p β (SE) p 
Total 
cholesterol 
0.002 
(0.001) 
0.172 -0.001 
(0.0004)
0.100 0.001 
(0.002) 
0.631 -0.004 
(0.002) 
0.036 
LDL 0.001 
(0.002) 
0.440 0.001 
(0.002) 
0.746 -0.0003 
(0.002) 
0.876 -0.001 
(0.002) 
0.690 
HDL -0.005 
(0.006) 
0.354 -0.001 
(0.006) 
0.891 -0.003 
(0.006) 
0.573 -0.002 
(0.007) 
0.756 
Triglycerides 0.001 
(0.001) 
0.121 -0.001 
(0.0004)
0.005 0.001 
(0.001) 
0.231 -0.001 
(0.0005) 
0.009 
Systolic BP 0.008 
(0.005) 
0.065 0.003 
(0.003) 
0.274 0.005 
(0.005) 
0.362 0.003 
(0.003) 
0.438 
Diastolic BP 0.025  
(0.008) 
0.001 0.003 
(0.005) 
0.476 0.023 
(0.008) 
0.006 0.002 
(0.005) 
0.747 
Heart rate 0.027 
(0.006) 
< 
0.001 
0.019 
(0.004) 
< 
0.001
0.029 
(0.007) 
< 
0.001
0.021 
(0.004) 
< 
0.001 
Waist/hip 
ratio 
0.635 
(0.788) 
0.421 -0.584 
(1.243) 
0.638 0.328 
(0.833) 
0.693 -0.033 
(1.239) 
0.979 
Daily sleep 0.032 0.676 -0.031 0.402 -0.005 0.955 -0.027 0.477 
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(hours) (0.077) (0.037) (0.083) (0.038) 
*Adjusted for age, Beck depression score, smoking status, alcohol drinking status, infection history and (for analyses 
dealing with heart rate and BP) beta blocker use. 
 
Obese 
 
 In the obese subgroup, the predictive model for CRP included BMI, dietary 
glycemic load and Beck depression score; adjustment was also made for infection history 
and beta blocker use.  No significant associations were found in the adjusted analysis.  
However, there was a trend toward an inverse longitudinal association between total 
cholesterol and CRP levels, and toward a positive cross-sectional association of CRP 
levels with systolic blood pressure and daily hours of sleep.   See table 11. 
 Table 11:  Association of lipids, BP, heart rate, WHR and daily sleep with natural-
log transformed CRP levels, obese subgroup 
 Unadjusted Adjusted* 
 Cross-sectional Longitudinal Cross-sectional  Longitudinal 
 β (SE) p β (SE) p β (SE) p β (SE) p 
Total 
cholesterol 
-0.002 
(0.002) 
0.336 -0.005 
(0.002) 
0.005 -0.0002 
(0.002) 
0.932 -0.003 
(0.002) 
0.073
LDL -0.003 
(0.002) 
0.234 -0.004 
(0.002) 
0.037 -0.001 
(0.002) 
0.767 -0.002 
(0.002) 
0.280
HDL -0.0003 
(0.007) 
0.967 0.002 
(0.006) 
0.745 -0.003 
(0.007) 
0.681 0.001 
(0.006) 
0.927
Triglycerides -0.0002 
(0.0004) 
0.649 -0.0005 
(0.0003)
0.108 -
0.00004 
(0.0005)
0.923 -0.001 
(0.0004) 
0.133
Systolic BP 0.008 
(0.005) 
0.109 -0.004 
(0.003) 
0.193 0.009 
(0.005) 
0.063 -0.003 
(0.003) 
0.272
Diastolic BP 0.009 
(0.010) 
0.382 -0.002 
(0.004) 
0.710 -0.002 
(0.011) 
0.882 0.002 
(0.004) 
0.718
Heart rate 0.029 
(0.008) 
0.001 -
0.00001 
(0.004) 
0.998 0.015 
(0.008) 
0.065 0.004 
(0.004) 
0.254
Waist/hip 
ratio 
-0.935 
(0.813) 
0.250 2.171 
(1.705) 
0.203 -0.125 
(0.819) 
0.879 1.761 
(1.691) 
0.298
Daily sleep 
(hours) 
0.143 
(0.087) 
0.101 -0.006 
(0.030) 
0.832 0.143 
(0.083) 
0.083 0.035 
(0.031) 
0.263
*Adjusted for BMI, dietary glycemic load, Beck depression score, infection history and (for analyses dealing with heart 
rate and BP) beta blocker use. 
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DISCUSSION 
Cross-sectional results for the association between CRP levels and traditional 
cardiovascular risk factors (lipids, blood pressure and resting heart rate), as well as 
waist/hip ratio, were generally consistent with findings from previous studies.  Some 
longitudinal results, however, were unexpected; others were somewhat expected but the 
biological mechanism has not been elucidated.  Further study is needed to examine these 
associations. 
Association of CRP with lipid levels 
 Interestingly, CRP levels showed an inverse longitudinal association with total 
cholesterol and triglyceride levels in the overall cohort, accounted for by the association 
present in men, and in the overweight subgroup.  There was a trend toward a similar 
association for total cholesterol in the obese subgroup.  This is the opposite of what was 
expected in light of the unadjusted cross-sectional associations, which agreed with the 
findings of previous (cross-sectional) studies.  In addition, triglyceride levels are known 
to increase during infection and inflammation, a situation where CRP levels obviously 
increase (Khovidhunkit et al., 2000).  From this, one would have expected a positive 
longitudinal association between triglyceride and CRP levels, but this is not what was 
found.  LDL cholesterol levels, on the other hand, are known to decrease during infection 
and inflammation (Khovidhunkit et al., 2000), so this may help explain the inverse 
longitudinal association seen with total cholesterol levels, although it is also possible that 
the inverse relation with triglycerides is, at least in part, responsible for the inverse 
relation with total cholesterol, since the triglyceride level is included in the total 
cholesterol level.  There was, in fact, a trend toward an inverse longitudinal association 
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between LDL cholesterol and CRP levels in the overall study cohort, consistent with a 
decrease in LDL levels in response to inflammation.  HDL levels have also been found to 
decrease during inflammation (Khovidhunkit et al., 2000), but no significant association 
between HDL and CRP levels was seen in this study.  Therefore, changes in HDL levels 
would not be responsible for the inverse association that was seen between total 
cholesterol and CRP levels.  In summary, there is some support in the literature for an 
inverse longitudinal association between total cholesterol and CRP levels, but the same 
cannot be said for triglycerides.  There also appears to be no biologically plausible 
explanation for the inverse association of CRP and triglycerides.  Further investigation of 
this relationship and its biological mechanism is needed. 
Association of CRP with blood pressure 
 There were no longitudinal associations found between either systolic or diastolic 
blood pressure and CRP levels.  However, there was a positive cross-sectional 
relationship between diastolic blood pressure and CRP levels in the overall study cohort 
and in the overweight subgroup, and there was a trend toward a positive cross-sectional 
association of CRP levels with systolic blood pressure in the overall cohort and the obese 
subgroup.  These findings differ somewhat from those of previous studies, which often 
found no association of CRP levels with diastolic blood pressure and if they did, always 
found a significant association with systolic blood pressure as well.  One possible reason 
for the difference is that the previous studies did not have such extensive dietary and 
other lifestyle data and therefore did not adjust for some of the factors for which 
adjustment was made in the present study.   
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Association of CRP with resting heart rate 
 By far the most consistent association found in this study was the positive 
relationship between resting heart rate and CRP levels.  This was found, cross-sectionally 
and/or longitudinally, in every analysis except that of the obese subgroup.  The 
association is unlikely to be explained by differences in physical activity levels or by 
infection status, as these were among the factors for which adjustment was made in the 
statistical analysis.  Although physical activity was not in the model for the overweight or 
obese subgroups, an analysis was performed in which it was forced in to determine 
whether it changed the association between CRP levels and heart rate.  The association 
did not substantially change, suggesting that it is not due to physical activity differences.  
One possible explanation is that elevated resting heart rate and increased CRP levels are 
associated simply due to both being indicators of suboptimal health, but it is not possible 
to conclusively establish this from the present study, since it was performed in a 
“healthy” population without known coronary heart disease or other chronic illness.  It is 
also possible that there is some hormonal or other factor that tends to increase both CRP 
and resting heart rate and that this is responsible for the association; however, there is no 
way to determine this from these results. 
Association of CRP with waist/hip ratio 
 No significant association was found between waist/hip ratio and CRP levels, in 
the overall cohort or in the BMI stratified analysis, when adjustment was made for other 
factors affecting CRP levels; that is, WHR was not found to be independently associated 
with CRP.  However, there was a positive cross-sectional association seen in women.  
There was also a trend toward a positive association in subjects with normal BMI.  One 
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possible explanation for the general lack of association seen between WHR and CRP is 
the fact that in most subjects, WHR changed very little over the course of the study.  In 
other words, an association could exist but subjects’ changes in WHR in this study were 
of insufficient magnitude for it to be apparent.  However, this does not account for the 
association that was seen in the women—there was no significant difference between 
men’s and women’s changes in WHR over the course of the study.   
Association of CRP with average daily sleep 
 There was a positive cross-sectional association between average daily sleep time 
and CRP levels in the overall cohort and in the subgroup with normal BMI; there was a 
trend toward such an association in the obese subgroup.  No longitudinal relationship was 
found.  This is very different from the association that would be expected in light of the 
experimental study by Meier-Ewert et al. (2004), which found CRP levels to increase 
with sleep deprivation.  However, that study examined the effects of severe sleep 
deprivation over a short period and under controlled conditions, as opposed to observing 
the effects of naturally-occurring fluctuations in sleep patterns in a free-living 
environment.  The positive cross-sectional association could reflect the fact that increased 
CRP is a sign of a problem somewhere in the body, and more sleep is needed in this 
situation for the body to repair itself.  However, it is not possible to make a definite 
conclusion such as this from an observational study. 
Strengths of study 
 The SEASONS data set contains measurements of many variables that could 
affect CRP levels and other cardiovascular risk factors.  This allowed careful examination 
of possible confounders, as well as adjustment for factors found to be significantly related 
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to CRP levels in the cohort.    In addition, the data set contains up to five measurements 
from each subject, over a one-year period.  This yielded new information, as longitudinal 
studies had not previously been conducted on the association of CRP levels and 
traditional cardiovascular risk factors. 
Limitations of study 
 One major limitation of this study is the lack of detailed data on infection and 
inflammation history.  When the original SEASONS study was conducted, there were no 
plans for the present study on the relation of other factors to CRP levels.  Consequently, 
the only information gathered on infection/inflammation history was whether a subject 
had had a cold, flu, allergy or other illness within the three months preceding the clinic 
visit, and whether any illness was severe enough to warrant missing work or being 
hospitalized.  There is no specific information as to when during that time the illness 
occurred, and it is likely that subjects would have had difficulty recalling a minor illness 
closer to the beginning of the three months.  The other major limitation is that 
information on medication use was only collected at baseline and one year, not at each 
clinic visit.  This makes it difficult to reliably control for medication use, as it is quite 
possible for a subject to have been taking a medication at the beginning of the study but 
not later on; many medications are taken on a short-term basis.  Therefore, it was not 
possible to control for the use of anti-inflammatory medications etc. which could affect 
CRP levels. 
Future studies 
 To further explore the inverse longitudinal association between triglyceride and 
CRP levels, it would be useful to conduct an intervention study of patients with elevated 
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triglyceride and CRP levels, in which they are given treatment to lower their triglycerides 
and the changes in CRP levels are also monitored.  This would help to show whether 
lowering triglyceride levels somehow causes CRP levels to increase, or whether the 
association seen in this study was likely due to some other reason.  A similar study could 
be done to examine the similar association found between CRP and total cholesterol 
levels, although care would need to be taken not to use a treatment that is known to lower 
both cholesterol and CRP levels, such as the statin drugs, which appear to lower CRP 
levels independent of LDL lowering (Ridker et al., 2005).  Another area that warrants 
further study is the positive association of resting heart rate and CRP levels, both cross-
sectionally and longitudinally.   
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APPENDIX A:  STATA CODE SAMPLES 
 
Cross-sectional model building, overall study cohort stratified by gender 
 
use "C:\Documents and Settings\hafnera\My Documents\Andrea MQP\x-
sectionalcrpdataset_withinf.dta", clear 
 
**Men** 
 
xi: regress logmeancrp i.smoking_status if gender == 0 
xi: regress logmeancrp i.drinker if gender == 0 
xi: regress logmeancrp i.employed if gender == 0 
xi: regress logmeancrp i.marital if gender == 0 
xi: regress logmeancrp i.ever_inf if gender == 0 
xi: regress logmeancrp i.race2 if gender == 0 
xi: regress logmeancrp i.education if gender == 0 
xi: regress logmeancrp i.SAdis if gender == 0 
xi: regress logmeancrp i.betablockers if gender == 0 
regress logmeancrp meanleisuremets if gender == 0 
regress logmeancrp meankcals if gender == 0 
regress logmeancrp meancarbpcnt if gender == 0 
regress logmeancrp meanprotpcnt if gender == 0 
regress logmeancrp meanfiber if gender == 0 
regress logmeancrp meanwater if gender == 0 
regress logmeancrp meansfpcnt if gender == 0 
regress logmeancrp nsfatpcntavg if gender == 0 
regress logmeancrp dailyGIwbavg if gender == 0 
regress logmeancrp meananx if gender == 0 
regress logmeancrp meandep if gender == 0 
regress logmeancrp age if gender == 0 
regress logmeancrp bmiavg if gender == 0 
regress logmeancrp tcavg if gender == 0 
regress logmeancrp ldlavg if gender == 0 
regress logmeancrp hdlavg if gender == 0 
regress logmeancrp tgavg if gender == 0 
regress logmeancrp sbpavg if gender == 0 
regress logmeancrp dbpavg if gender == 0 
regress logmeancrp hravg if gender == 0 
regress logmeancrp whravg if gender == 0 
 
xi: sw regress logmeancrp i.smoking_status i.education meanleisuremets meancarbpcnt 
meanfiber meansfpcnt nsfatpcntavg dailyGIwbavg meandep age bmiavg if gender == 0, 
pr(0.20) 
 
 
**Women** 
 
xi: regress logmeancrp i.smoking_status if gender == 1 
xi: regress logmeancrp i.drinker if gender == 1 
xi: regress logmeancrp i.employed if gender == 1 
xi: regress logmeancrp i.marital if gender == 1 
xi: regress logmeancrp i.ever_inf if gender == 1 
xi: regress logmeancrp i.race2 if gender == 1 
xi: regress logmeancrp i.education if gender == 1 
xi: regress logmeancrp i.SAdis if gender == 1 
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xi: regress logmeancrp i.betablockers if gender == 1 
regress logmeancrp meanleisuremets if gender == 1 
regress logmeancrp meankcals if gender == 1 
regress logmeancrp meancarbpcnt if gender == 1 
regress logmeancrp meanprotpcnt if gender == 1 
regress logmeancrp meanfiber if gender == 1 
regress logmeancrp meanwater if gender == 1 
regress logmeancrp meansfpcnt if gender == 1 
regress logmeancrp nsfatpcntavg if gender == 1 
regress logmeancrp dailyGIwbavg if gender == 1 
regress logmeancrp meananx if gender == 1 
regress logmeancrp meandep if gender == 1 
regress logmeancrp age if gender == 1 
regress logmeancrp bmiavg if gender == 1 
regress logmeancrp tcavg if gender == 1 
regress logmeancrp ldlavg if gender == 1 
regress logmeancrp hdlavg if gender == 1 
regress logmeancrp tgavg if gender == 1 
regress logmeancrp sbpavg if gender == 1 
regress logmeancrp dbpavg if gender == 1 
regress logmeancrp hravg if gender == 1 
regress logmeancrp whravg if gender == 1 
 
xi: sw regress logmeancrp i.smoking_status i.education meanleisuremets meankcals 
meancarbpcnt meanprotpcnt meanfiber meansfpcnt meandep age bmiavg if gender == 1, 
pr(0.20) 
 
 
Example of longitudinal analysis using model built by cross-sectional process 
use "C:\Documents and Settings\hafnera\My Documents\Andrea MQP\longitudinal-with-
infection.dta", clear 
 
**Generating mean and residual values for each covariate and variable of interest** 
 
foreach y in logcrp BMI sports_metsavg carbohydrate_percentavg protein_percentavg 
dietary_fiberavg satfat_percentavg nsatfat_percentavg energy_caloriesavg sleephrsavg 
beck_d beck_a tc ldl hdl tg Systolic_BP Diastolic_BP heartrate dailyGI_whitebreadQ 
dailyGL_whitebreadQ drinks whr {  
egen `y'_mean = mean(`y'), by(id) 
gen `y'_res = `y' - `y'_mean 
} 
 
tsset, clear 
 
**Example of longitudinal analysis, using model built by cross-sectional process** 
 
#delimit; 
 
xi: xtgee logcrp age 
BMI_mean BMI_res 
protein_percentavg_mean protein_percentavg_res 
beck_d_mean beck_d_res 
sports_metsavg_mean sports_metsavg_res 
ldl_mean ldl_res  **or other variable of interest** 
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i.smoking_status 
i.infe_infla,  **also beta blocker use, for analyses with HR or BP** 
i(id) t(quarter) corr(ar1) force; 
 
**repeat for each gender separately and BMI groups (normal, overweight, obese) using 
appropriate model** 
 
